'Maybe I Shouldn't Talk': The Role of Power in the Telling of Mental Health Recovery Stories.

marginalised or vulnerable populations mental health and illness recovery stigma

Journal

Qualitative health research
ISSN: 1049-7323
Titre abrégé: Qual Health Res
Pays: United States
ID NLM: 9202144

Informations de publication

Date de publication:
10 2022
Historique:
pubmed: 19 8 2022
medline: 28 9 2022
entrez: 18 8 2022
Statut: ppublish

Résumé

Mental health 'recovery narratives' are increasingly used within teaching, learning and practice environments. The mainstreaming of their use has been critiqued by scholars and activists as a co-option of lived experience for organisational purposes. But how people report their experiences of telling their stories has not been investigated at scale. We present accounts from 71 people with lived experience of multiple inequalities of telling their stories in formal and informal settings. A reflexive thematic analysis was conducted within a critical constructivist approach. Our overarching finding was that questions of power were central to all accounts. Four themes were identified: (1) Challenging the status quo; (2) Risky consequences; (3) Producing 'acceptable' stories; (4) Untellable stories. We discuss how the concept of narrative power foregrounds inequalities in settings within which recovery stories are invited and co-constructed, and conclude that power imbalances complicate the seemingly benign act of telling stories of lived experience.

Identifiants

pubmed: 35979858
doi: 10.1177/10497323221118239
pmc: PMC9511241
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

1828-1842

Subventions

Organisme : Department of Health
ID : RP-PG-0615-20016
Pays : United Kingdom

Références

Qual Health Res. 2021 Jul;31(9):1567-1569
pubmed: 34027724
Qual Health Res. 2012 Mar;22(3):304-19
pubmed: 21900694
Int J Integr Care. 2017 Jul 21;17(4):2
pubmed: 28970760
Health (London). 2016 Nov;20(6):599-615
pubmed: 26304707
Soc Psychiatry Psychiatr Epidemiol. 2019 Jan;54(1):51-58
pubmed: 30069754
Psychol Med. 2020 Apr;50(5):705-726
pubmed: 32063250
Soc Sci Med. 2021 Jul;281:114101
pubmed: 34120087
Cult Med Psychiatry. 2022 Jun;46(2):221-247
pubmed: 30895516
Can J Psychiatry. 2019 Oct;64(10):669-679
pubmed: 31046432
Int J Environ Res Public Health. 2020 Apr 27;17(9):
pubmed: 32349269
Soc Psychiatry Psychiatr Epidemiol. 2020 Mar;55(3):295-308
pubmed: 31654089
Psychol Serv. 2019 Aug;16(3):456-462
pubmed: 30382746
Qual Health Res. 2020 Mar;30(4):634-649
pubmed: 31729934
Psychiatr Rehabil J. 2020 Jun;43(2):111-120
pubmed: 31355653
Qual Health Res. 2019 Jul;29(9):1266-1276
pubmed: 30616464
Soc Sci Med. 2021 Jun;279:113981
pubmed: 33991793
J Ment Health. 2018 Aug;27(4):298-306
pubmed: 28648112
Psychiatr Rehabil J. 2001 Spring;24(4):335-43
pubmed: 11406984
BMC Psychiatry. 2019 Dec 27;19(1):417
pubmed: 31881957
JMIR Ment Health. 2018 May 08;5(2):e37
pubmed: 29739737
Qual Health Res. 2021 Oct;31(12):2194-2210
pubmed: 34414821
JMIR Form Res. 2021 May 27;5(5):e24417
pubmed: 34042595
JMIR Ment Health. 2019 Oct 4;6(10):e14233
pubmed: 31588912
Schizophr Bull. 2022 Jan 21;48(1):134-144
pubmed: 34423840
PLoS One. 2021 Apr 16;16(4):e0250367
pubmed: 33861807
JMIR Ment Health. 2020 Sep 18;7(9):e16290
pubmed: 32945771
Psychiatr Rehabil J. 2001 Winter;24(3):248-56
pubmed: 11315211
World Psychiatry. 2020 Oct;19(3):389-390
pubmed: 32931101
J Ment Health. 2014 Oct;23(5):217-8
pubmed: 24988317
Clin Psychol Rev. 2015 Aug;40:40-56
pubmed: 26051308
BMC Public Health. 2018 Jul 27;18(1):919
pubmed: 30049270
J Psychiatr Ment Health Nurs. 2021 Aug;28(4):578-589
pubmed: 33295065
PLoS One. 2019 Mar 28;14(3):e0214678
pubmed: 30921432
J Ment Health. 2018 Oct;27(5):475-481
pubmed: 29768960
Patient Educ Couns. 2019 Jul;102(7):1273-1279
pubmed: 30791990
Psychol Med. 2017 Aug;47(11):1867-1879
pubmed: 28196549
J Ment Health. 2019 Aug;28(4):341-344
pubmed: 31070066
PLoS One. 2019 Dec 13;14(12):e0226201
pubmed: 31834902
J Ment Health. 2018 Oct;27(5):383-387
pubmed: 30345848
BMJ Open. 2019 Jun 28;9(6):e029342
pubmed: 31256037
Clin Psychol Rev. 2020 Jun;78:101843
pubmed: 32304914

Auteurs

Joy Llewellyn-Beardsley (J)

School of Health Sciences, Institute of Mental Health, 6123University of Nottingham, Nottingham, UK.

Stefan Rennick-Egglestone (S)

School of Health Sciences, Institute of Mental Health, 6123University of Nottingham, Nottingham, UK.

Kristian Pollock (K)

School of Health Sciences, 6123University of Nottingham, Nottingham, UK.

Yasmin Ali (Y)

School of Health Sciences, Institute of Mental Health, 6123University of Nottingham, Nottingham, UK.

Emma Watson (E)

5314Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK.

Donna Franklin (D)

NEON Lived Experience Advisory Panel, 6123University of Nottingham, Nottingham, UK.

Caroline Yeo (C)

School of Health Sciences, Institute of Mental Health, 6123University of Nottingham, Nottingham, UK.

Fiona Ng (F)

School of Health Sciences, Institute of Mental Health, 6123University of Nottingham, Nottingham, UK.

Rose McGranahan (R)

Independent researcher, London, UK.

Mike Slade (M)

School of Health Sciences, Institute of Mental Health, 6123University of Nottingham, Nottingham, UK.

Alison Edgley (A)

School of Health Sciences, 6123University of Nottingham, Nottingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH